Autophagy-related-gene signature predicts survival outcomes and the tumor immune landscape in skin cutaneous melanoma
Eurasian Journal of Medicine and Oncology · 12.08.2026 · 10 (5) · 025370399
DOI: 10.36922/ejmo025370399 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 12.08.2026. Verfasst von Yadong Xue und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Skin cutaneous melanoma (SKCM) is a malignant skin cancer characterized by heterogeneous outcomes. Autophagy exerts dual effects on tumor progression and immune modulation.
Objective
This study aims to investigate whether autophagy-related genes can stratify melanoma patients with different prognoses and to examine their association with the immune microenvironment.
Methods
We identified 371 autophagy-related genes from the Human Autophagy Database and analyzed transcriptomic and clinical data from 405 SKCM cases from The Cancer Genome Atlas (TCGA). An autophagy-based prognostic signature was initially screened by univariate Cox regression and then refined using Least Absolute Shrinkage and Selection Operator Cox regression. Risk scores derived from this signature classified patients into high- and low-risk groups, and the predictive power of the signature was validated in TCGA and Gene Expression Omnibus datasets. Functional enrichment, differential expression, and immune deconvolution analyses (Cell-type Identification by Estimating Relative Subsets of Known RNA Transcripts) were used to explore molecular and immune differences between groups.
Results
We constructed a 102-autophagy-related-gene signature, which robustly stratifies patients with distinct survival outcomes in different cohorts. Low-risk tumors exhibited immune-activating transcriptional programs and higher infiltration of cluster of differentiation (CD)8+ T lymphocytes, natural killer cells, plasma cells, and memory CD4+ T lymphocytes. High-risk tumors were associated with oncogenic signaling pathways and immunosuppressive subsets, such as M2 macrophages and Tregs. Canonical immune checkpoints, including PDCD1, CD274, CTLA4, LAG3, and TIGIT, were upregulated in the low-risk group and correlated significantly with effector immune infiltration, presenting an “immune-inflamed” phenotype.
Conclusion
This autophagy-related-gene signature distinguished prognostic subgroups and highlighted biological and immune diversity in melanoma, providing potential directions for future autophagy research.
Zitieren
APA
Xue, Y., Xie, Y., Zhang, X., & Yin, M. (2026). Autophagy-related-gene signature predicts survival outcomes and the tumor immune landscape in skin cutaneous melanoma. Eurasian Journal of Medicine and Oncology, 10(5), 025370399. https://doi.org/10.36922/ejmo025370399
Vancouver
Xue Y, Xie Y, Zhang X, Yin M. Autophagy-related-gene signature predicts survival outcomes and the tumor immune landscape in skin cutaneous melanoma. Eurasian Journal of Medicine and Oncology. 2026;10(5):025370399. doi:10.36922/ejmo025370399
BibTeX
@article{Xue2026,
author = {Xue, Yadong and Xie, Yunjin and Zhang, Xiyuan and Yin, Mingzhu},
title = {Autophagy-related-gene signature predicts survival outcomes and the tumor immune landscape in skin cutaneous melanoma},
journal = {Eurasian Journal of Medicine and Oncology},
year = {2026},
volume = {10},
number = {5},
pages = {025370399},
doi = {10.36922/ejmo025370399}
}
EUVIMED